MedCrypt
and QuiO said earlier this month that the companies are partnering to integrate MedCrypt’s data security software into QuiO’s Smartinjector devices.
According to the agreement, MedCrypt will provide software security for QuiO’s Si One pen for specialty drugs and the Si Pen for diabetes patients. The companies plan to integrate the devices with software that can monitor real-time dosing data for suspicious behavior, like unusual dose amounts. The software also enables devices to sign and encrypt data communicated through QuiO’s cloud platform ConnectedRx.
Get the full story at our sister site, Drug Delivery Business News.
The post QuiO adds MedCrypt data security to Smartinjector pen appeared first on MassDevice.